NYSE:CRMD

Cormedix Stock Predictions

Healthcare > Biotechnology

Buy CRMD

*Your capital is at risk

$8.23

+0.0600 (+0.734%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CRMD Prediction Chart

CRMD Predictions History

Latest community submissions for CRMD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Christi.SC.Closeouts.89991	Oct 2, 2018	$0.95 -84.15%	$1.20	V	79.20%	0
Dolphin	Oct 2, 2018	$0.151 -97.48%	$1.20	V	12.60%	0
HoodedMonk	Sep 28, 2018	$0.650 -86.60%	$0.97	V	67.10%	0
JS Pro	Sep 4, 2018	$0.654 -79.24%	$0.620	X	95.40%	0
JS Pro	Aug 14, 2018	$0.617 -77.56%	$0.550	X	87.80%	0
JS Pro	Aug 2, 2018	$0.536 -83.51%	$0.650	V	83.00%	0
willyp1091	Aug 2, 2018	$0.620 -80.92%	$0.650	X	96.10%	0
JS Pro	Aug 1, 2018	$0.565 -79.82%	$0.560	V	99.00%	1
JS Pro	Jul 30, 2018	$0.445 -87.29%	$0.700	V	63.60%	0
Tim.Napier.84355	Jul 30, 2018	$0.430 -87.71%	$0.700	V	61.40%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRMD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CORMEDIX INC

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical setting...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by